Last reviewed · How we verify
NCT06012682: METIN
Clinical Trials Evaluating the Effect of Metformin Treatment on Function Endometrium in Women Diagnosed With Idiopathic Infertility
Phase 2 trial testing Metformin Hydrochloride in Infertility, Female in 200 participants. Not yet recruiting.
30 September 2027
Quick facts
| Lead sponsor | Medical University of Bialystok |
|---|---|
| Phase | Phase 2 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 30 August 2023 |
| Primary completion | 30 September 2027 |
| Estimated completion | 30 September 2027 |
Drugs / interventions tested
- Metformin Hydrochloride — full drug profile →
- Placebo
Conditions studied
- Infertility, Female — all drugs for Infertility, Female →
Sponsor
Medical University of Bialystok
Who can join
Adults 18 to 45, female only, with Infertility, Female. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Randomized, controlled, double-blind, three-arm clinical trial in which 75 women will be randomized to treatment with metformin, 75 women to treatment with placebo and 50 women to the observation group. The medical intervention will last 24 weeks (6 months). Women with confirmed idiopathic infertility, in whom infertility factors have been excluded during full diagnostics, will be included in the study
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06012682
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Metformin Hydrochloride
Trials testing the same drug.
- NCT07380841 — Metformin vs Inositol vs Diet vs Combination Therapy in PCOS · NA · completed
- NCT06899061 — Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saru · Phase 1 · active not recruiting
- NCT06920056 — A Study of BGM0504 in Overweight or Obese Participants · Phase 1 · completed
- NCT06638671 — Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity · Phase 4 · recruiting
- NCT05828303 — A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastat · Phase 1 · withdrawn
Other recruiting trials for Infertility, Female
Currently open trials in the same condition.
- NCT06771401 — Identification of Biomarkers in Cervical Mucus · NA · recruiting
- NCT06984081 — CAPA In-vitro Oocyte Maturation · NA · recruiting
- NCT07308561 — The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Under · recruiting
- NCT07175571 — SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques · NA · recruiting
- NCT06193135 — Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitar · NA · recruiting
Other Medical University of Bialystok trials
Trials by the same sponsor.
- NCT07496957 — Preserflo MicroShunt Versus Trabeculectomy · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07325552 — iStent Inject Versus Goniotomy With Kahook Dual Blade in Glauocma Treatment · NA · recruiting
- NCT07529145 — Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment · recruiting
- NCT06855979 — The Impact of Dietary Intervention on Oxidative/antioxidant Markers and Gut Microbiota in Athletes · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06012682 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Bialystok
- Last refreshed: 25 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06012682.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing